Tril - TLR4 interactor with leucine-rich repeats Gene
Also Known as RGD1310827
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 362364
Summary
Predicted to enable lipopolysaccharide binding activity. Predicted to be involved in regulation of cytokine production involved in immune response and Toll-like Receptor 4 signaling pathway. Predicted to be part of lipopolysaccharide receptor complex. Predicted to be active in extracellular matrix and extracellular space. Orthologous to human TRIL (TLR4 interactor with leucine rich repeats). [provided by Alliance of Genome Resources, Apr 2022]
Tril Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001034010.2 | NP_001029182.1 | TLR4 interactor with leucine rich repeats precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
TLR4 interactor with leucine rich repeats |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS15018 | TRIL Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19966 | Tril Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26469 | Tril Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service